Pembrolizumab recommended for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma

Pembrolizumab monotherapy works better than chemotherapy alone for cancers that have started outside the oral cavity, says NICE guidance.

Please sign in or register for FREE

No comments yet.